Urology · Murrieta, CA
NPI
1972747988
Since 2009
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
25495 Medical Center Dr Ste 204
Murrieta, CA, 92562
Phone (951) 698-1901
Groups this clinician bills Medicare through
Medicare paid, 2024
$308K
11,019 services
Medicare patients, 2024
621
Average age 76
Drug cost, 2024
$1.8M
1,751 prescriptions
Company payments, 2025
$1,588
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin T Larson was code J0897 (injection, denosumab, 1 mg), 3,541 times for 15 patients. In total Benjamin T Larson billed 11,019 services in 92 codes, and Medicare paid $308K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,541 | 15 | $16.64 | $59K |
| 99214 Office E&M - Established | Office | 804 | 436 | $97.62 | $78K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 546 | 356 | $12.59 | $6,873 |
| 81002 Clinical Chemistry | Office | 510 | 313 | $3.40 | $1,734 |
| 51798 Ultrasound - Nonspecific | Office | 428 | 279 | $8.90 | $3,808 |
| 97140 PT Treatment | Office | 232 | 18 | $14.00 | $3,249 |
| 97530 PT Treatment | Office | 193 | 25 | $21.06 | $4,064 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 138 | 20 | $116.53 | $16K |
| 97112 PT Treatment | Office | 121 | 14 | $16.64 | $2,013 |
| 52000 Cystourethroscopy | Office | 111 | 92 | $193.65 | $21K |
| 99204 Office E&M - New | Office | 68 | 68 | $124.86 | $8,491 |
| 51700 Other Organ Systems | Office | 67 | 59 | $51.94 | $3,480 |
| 96402 Chemotherapy Administration | Office | 46 | 33 | $29.73 | $1,368 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 39 | 16 | $50.58 | $1,973 |
| 96372 Injection Administration | Office | 37 | 19 | $11.84 | $438 |
By year: 2022 $248K for 9,871 services; 2023 $280K for 8,839 services; 2024 $308K for 11,019 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 510 | 313 | $3.40 | $1,734 |
| 81003 Clinical Chemistry | 14 | 14 | $2.20 | $30.8 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin T Larson prescribed most often to Medicare patients was Tamsulosin Hcl, with 475 prescriptions and refills. In total Benjamin T Larson wrote 1,751 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 475 | 1,313 | 190 | $5,708 |
| Finasteride Generic | 137 | 400 | 59 | $1,661 |
| Tramadol Hcl Generic | 118 | 118 | 114 | $204 |
| Oxybutynin Chloride Generic | 91 | 93 | 84 | $416 |
| Ciprofloxacin Hcl Generic | 71 | 71 | 66 | $214 |
| Gemtesa Vibegron | 62 | 130 | 19 | $60K |
| Orgovyx Relugolix | 61 | 61 | 11 | $194K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 57 | 57 | 53 | $514 |
| Myrbetriq Mirabegron | 54 | 95 | 22 | $41K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 138 | 26 | $1,027 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 47 | 46 | $105 |
| Xgeva Denosumab | 46 | 46 | Under 11 | $145K |
| Estradiol Generic | 42 | 138 | 33 | $2,694 |
| Erleada Apalutamide | 37 | 39 | Under 11 | $575K |
| Solifenacin Succinate Generic | 34 | 92 | 18 | $1,976 |
Brand drugs: 366 claims; generic drugs: 1,385 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin T Larson $1,588 ($1,588 in general payments such as food, travel and fees) from 21 companies. The largest payer was Procept Biorobotics Corporation with $296.
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation PRCT | 5 | $296 |
| Abbvie Inc. ABBV | 10 | $186 |
| Dendreon Pharmaceuticals LLC | 5 | $155 |
| Janssen Biotech, Inc. JNJ | 8 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $135 |
| Accord Healthcare, Inc. | 5 | $109 |
| Verity Pharmaceuticals Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $101 |
| Astellas Pharma US Inc 4503.T | 2 | $55.55 |
| Blue Earth Diagnostics | 1 | $38.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.